Systemic Exposure to Fluticasone Propionate Administered via Metered-Dose Inhaler Containing Chlorofluorocarbon or Hydrofluoroalkane Propellant

被引：0
|
作者：
Alison E. Mackie
Jo E. McDowall
Pietro Ventresca
Alan Bye
Christine Falcoz
Peter T. Daley-Yates
机构：
[1] Lilly Research Centre,Clinical Pharmacology
[2] Glaxo Wellcome Research and Development,undefined
[3] Glaxo Wellcome Research and Development,undefined
来源：
Clinical Pharmacokinetics | 2000年 / 39卷
关键词：
Fluticasone Propionate; Absolute Bioavailability; Chlorofluorocarbon; Urinary Cortisol; Urinary Cortisol Excretion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：17 / 22
页数：5
相关论文
共 50 条
  • [21] The chlorofluorocarbon to hydrofluoroalkane transition: The effect on pressurized metered dose inhaler suspension stability
    Brindley, A
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (06) : S221 - S226
  • [22] Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma
    Condemi, JJ
    Chervinsky, P
    Goldstein, MF
    Ford, LB
    Berger, WE
    Ayars, GH
    Rogenes, PR
    Edwards, L
    Pepsin, PJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (04) : 467 - 474
  • [23] CLINICAL EQUIVALENCE OF A NOVEL NON-CHLOROFLUOROCARBON-CONTAINING SALBUTAMOL SULFATE METERED-DOSE INHALER AND A CONVENTIONAL CHLOROFLUOROCARBON INHALER IN PATIENTS WITH ASTHMA
    DOCKHORN, R
    VANDENBURGT, JA
    EKHOLM, BP
    DONNELL, D
    CULLEN, MT
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 96 (01) : 50 - 56
  • [24] Lower systemic exposure and reduced systemic pharmacodynamic effects from a combination salmeterol/fluticasone propionate metered-dose inhaler compared to individual inhalers in healthy subjects
    Kunka, RL
    Yin, Y
    Andrews, SMS
    York, M
    Callahan, K
    Kirby, S
    Daley-Yates, PT
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S239 - S239
  • [25] Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD
    Bhattacharya, Amal
    Bhargava, Salil
    Singh, Virendra
    Talwar, Deepak
    Whig, Jagdeep
    Rebello, Juliet
    Purandare, Shrinivas
    Gogtay, Jaideep
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 1469 - 1476
  • [26] Cost-effectiveness of fluticasone propionate administered via metered-dose inhaler plus BabyhalerTM spacer in the treatment of asthma in preschool-aged children
    Bisgaard, H
    Price, MJ
    Maden, C
    Olsen, NA
    CHEST, 2001, 120 (06) : 1835 - 1842
  • [27] Pharmacokinetic Study of Epinephrine Hydrofluoroalkane (Primatene MIST) Metered-Dose Inhaler
    Kerwin, Edward M.
    Marrs, Tony
    Luo, Mary Z.
    Zhang, Jack Y.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2020, 33 (05) : 282 - 287
  • [28] Evaluation of particle size distribution of albuterol sulfate hydrofluoroalkane administered via metered-dose inhaler with and without valved holding chambers
    Crim, C
    Holmes, M
    Lee, B
    Cavanaugh, R
    Lincourt, W
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 94 (01) : 80 - 85
  • [29] Efficacy of fluticasone metered-dose inhaler and dry powder inhaler for pediatric asthma
    Miyahara, Hiroaki
    Korematsu, Seigo
    Nagakura, Tomokazu
    Izumi, Tatsuro
    PEDIATRICS INTERNATIONAL, 2008, 50 (01) : 103 - 108
  • [30] A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects
    Tripp, Kenneth
    McVicar, William K.
    Nair, Parameswaran
    Corren, Jonathan
    Pleskow, Warren W.
    Goodwin, Elizabeth
    Baumgartner, Rudolf A.
    Hanrahan, John P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) : 544 - 549
12345